References
- Cancer in Slovenia 2015. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia, 2018.
- Cufer T, Kosnik M. [Clinical Registry of Lung Cancer Patients]. [Slovenian]. Onkologija 2013; 1: 8-10.
- Postmus PE, Kerr KM, Oudkerk M, Waller DA, Vansteenkiste J, Escriu C, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2017; 28(Suppl 4): 1-21. doi: 10.1093/annonc/mdx222
- Lindberg K, Nyman J, Kallskog VR, Hoyer M, Lund A, Lax I, et al. Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT - the Nordic experience. Acta Oncol 2015; 54: 1096-104. doi: 10.3109/0284186X.2015.1020966
- Verstegen NE, Lagerwaard FJ, Hashemi SM, Dahele M, Slotman BJ, Senan S. Patterns of disease recurrence after SABR for early stage non-small-cell lung cancer: optimizing follow-up schedules salvage therapy. J Thorac Oncol 2015; 10: 1195-200. doi: 10.1097/JTO.0000000000000576
- Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824. doi: 10.1164/rccm.2009-040GL
- Rudd RM, Prescott RJ, Chalmers JC, Johnston IDA; Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. British Thoracic Society Study on cryptogenic fibrosing alveolitis: response to treatment and survival. Thorax 2007; 62: 62-66. doi: 10.1136/ thx.2005.045591
- Raghu G, Amatto VC, Behr J, Stowasser S. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review. Eur Respir J 2015; 46: 1113-30. doi: 10.1183/13993003.02316-2014
- Omori T, Tajiri M, Baba T, Ogura T, Iwasawa T, Okudela K, et al. Pulmonary resection for lung cancer in patients with idiopathic interstitial pneumonia. Ann Thorac Surg 2015; 100: 954-60. doi: 10.1016/j.athoracsur.2015.03.094
- Saito Y, Kawai Y, Takahashi N, Ikeya T, Murai K, Kawabata Y, et al. Survival after surgery for pathologic stage IA non-small-cell lung cancer associated with idiopathic pulmonary fibrosis. Ann Thorac Surg 2011; 92: 1812-7. doi: 10.1016/j.athoracsur.2011.06.055
- Lee T, Park JY, Lee HY, Cho YJ, Yoon HI, Lee JH, et al. Lung cancer in patients with idiopathic pulmonary fibrosis: clinical characteristics and impact on survival. Respir Med 2014; 108: 1549-55. doi: 10.1016/j.rmed.2014.07.020
- Ghatol A, Ruhl AP, Danoff SK. Exacerbations in idiopathic pulmonary fibrosis triggered by pulmonary and nonpulmonary surgery: a case series and comprehensive review of the literature. Lung 2012; 190: 373-80. doi: 10.1007/ s00408-012-9389-5
- Ueki N, Matsuo Y, Togashi Y, Kubo T, Shibuya K, Iizuka Y, et al. Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer. J Thorac Oncol 2015: 10: 116-25. doi: 10.1097/JTO.0000000000000359
- Isobe K, Hata Y, Sakamoto S, Takai y, Shibuya K, Homma S. Clinical characteristics of acute respiratory deterioration in pulmonary fibrosis associated with lung cancer following anti-cancer therapy. Respirology 2010; 15: 88-92. doi: 10.1111/j.1440-1843.2009.01666.x
- Yamaguchi S, Ohguri T, Ide S, Aoki T, Imada H, Yahara K, et al. Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: the potential risk of extensive radiation pneumonitis. Lung Cancer 2013; 82: 260-5. doi: 10.1016/j.lungcan.2013.08.024
- Takeda A, Sanuki N, Enomoto T, Kunieda E. Subclinical interstitial lung disease: is it a risk factor for fatal radiation pneumonitis following stereotactic body radiotherapy? Lung Cancer 2014; 83: 112. doi: 10.1016/j. lungcan.2013.10.009
- Goto T, Maeshima A, Oyamada Y, Kato R. Idiopathic pulmonary fibrosis as a prognostic factor in non-small cell lung cáncer. Int J Clin Oncol 2014; 19: 266-73. doi: 10.1007/s10147-013-0566-1
- Kawasaki H, Nagai K, Yoshida J, Nishimura M, Nishiwaki Y. Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis. J Surg Oncol 2002; 81: 33-7. doi: 10.1002/jso.10145
- Naccche J, Gibiot Q, Monnet I, Antoine M, Wislez M, Chouaid C, et al. Lung cancer and interstitial lung disease: a literature review. J Thorac Dis 2018; 10: 3829-44. doi: 10.21037/jtd.2018.05.75
- Khan KA, Kennedy MP, Moore E, Crush L, Prendeville S, Maher MM, et al. Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis. Lung 2015; 193: 71-7. doi: 10.1007/s00408-014-9664-8
- Watanabe A, Miyajima M, Mishina T, Nakazawa J, Harada R, Kawaharada N, et al. Surgical treatment for primary lung cancer combined with idiopathic pulmonary fibrosis. Gen Thorac Cardiovasc Surg 2013; 61: 254-61. doi: 10.1007/s11748-012-0180-6
- Watanabe A, Higami T, Ohori S, Koyanagi T, Nakashima S. Mawatari T. Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? J Thorac Cardiovasc Surg 2008; 136: 1357-63. doi: 10.1016/j. jtcvs.2008.07.016
- Fujimoto T, Okazaki T, Matsukura T, Hanawana T, Yamashita N, Nishimura K, et al. Operation for lung cancer in patients with idiopathic pulmonary fibrosis: surgical contraindication? Ann Thorac Surgery 2003; 76: 1674-9. doi: 10.1016/S0003-4975(03)00966-4
- Martinez FJ, Chisholm A, Collard HR, Flaherty KR, Myers J, Raghu G, et al. The diagnosis of idiopathic pulmonary fibrosis: current and future approaches. Lancet Respir Med 2017; 5: 61-71. doi: 10.1016/S2213-2600(16)30325-3